Schupp, J.; Zimmer, N.; Kurch, S. et al.
Melanoma in the humanized mouse: What influence has the macrophage phenotype on tumor growth?EXPERIMENTAL DERMATOLOGY. Bd. 27. H. 3. 2018 S. E86-E86
Negwer, Inka; Best, Andreas; Schinnerer, Meike et al.
Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopyNATURE COMMUNICATIONS. Bd. 9. 2018
Raker, V. K.; Haub, J.; Lorenz, N. et al.
Monocyte recruitment and monocyte/platelet cluster formation in systemic sclerosisEXPERIMENTAL DERMATOLOGY. Bd. 27. H. 3. 2018 S. E46-E46
Schmitt, Jochen; Haufe, Eva; Trautmann, Freya et al.
Occupational UV-Exposure is a Major Risk Factor for Basal Cell Carcinoma: Results of the Population-Based Case-Control Study FB-181JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE. Bd. 60. H. 1. 2018 S. 36-43
Melhorn, S.; Staubach, P.
Octenidine dihydrochlorideHAUTARZT. Bd. 69. H. 5. 2018 S. 427-429
Staubach, P.; Metz, M.; Chapman-Rothe, N. et al.
Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study dataALLERGY. Bd. 73. H. 3. 2018 S. 576-584
Maurer, Marcus; Metz, Martin; Brehler, Randolf et al.
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidenceJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 141. H. 2. 2018 S. 638-649
Dummer, R.; Ascierto, P. A.; Gogas, H. J. et al.
Overall Survival (OS) in COLUMBUS: A Phase-III-Study with Encorafenib (ENCO) plus Binimetinib (BINI) versus Vemurafenib (VEM) or ENCO in BRAF mutant MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 16. 2018 S. 41-41
Dummer, Reinhard; Ascierto, Paolo A.; Gogas, Helen J. et al.
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trialLANCET ONCOLOGY. Bd. 19. H. 10. 2018 S. 1315-1327
Maurer, Marcus; Raap, U.; Staubach-Renz, Petra et al.
Patients with chronic spontaneous Urticaria have not yet been adequately treated: 1-year Data from the AWARE StudyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 16. 2018 S. 10-11